Atara Biotherapeutics (ATRA) Capital Expenditures Growth (3y) (2017 - 2024)
Atara Biotherapeutics (ATRA) Capital Expenditures Growth (3y) (2017 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -12.25% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -31.58% |
| Jun 30, 2024 | -57.70% |
| Dec 31, 2023 | -78.60% |
| Sep 30, 2023 | -17.64% |
| Jun 30, 2023 | -30.27% |
| Mar 31, 2023 | -47.40% |
| Dec 31, 2022 | -78.76% |
| Sep 30, 2022 | -26.79% |
| Jun 30, 2022 | -97.09% |
| Mar 31, 2022 | 48.47% |
| Dec 31, 2021 | 28.41% |
| Sep 30, 2021 | -29.50% |
| Jun 30, 2021 | 28.86% |
| Mar 31, 2021 | -51.95% |
| Dec 31, 2020 | -56.01% |
| Sep 30, 2020 | 33.77% |
| Jun 30, 2020 | -12.84% |
| Mar 31, 2020 | 3.39% |
| Dec 31, 2019 | 53.56% |
| Sep 30, 2019 | 18.74% |